220 related articles for article (PubMed ID: 31705397)
1. L-Carnitine counteracts in vitro fructose-induced hepatic steatosis through targeting oxidative stress markers.
Montesano A; Senesi P; Vacante F; Mollica G; Benedini S; Mariotti M; Luzi L; Terruzzi I
J Endocrinol Invest; 2020 Apr; 43(4):493-503. PubMed ID: 31705397
[TBL] [Abstract][Full Text] [Related]
2. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
3. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
4. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.
Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M
Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441
[No Abstract] [Full Text] [Related]
5. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L
World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic Acid Ameliorates Fructose-Induced Hepatic Steatosis Involving ER Stress Response in Primary Mouse Hepatocytes.
Zheng J; Peng C; Ai Y; Wang H; Xiao X; Li J
Nutrients; 2016 Jan; 8(1):. PubMed ID: 26805874
[TBL] [Abstract][Full Text] [Related]
7. Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis.
Salic K; Gart E; Seidel F; Verschuren L; Caspers M; van Duyvenvoorde W; Wong KE; Keijer J; Bobeldijk-Pastorova I; Wielinga PY; Kleemann R
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491949
[TBL] [Abstract][Full Text] [Related]
8. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
Patel TP; Rawal K; Soni S; Gupta S
Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
[TBL] [Abstract][Full Text] [Related]
9. Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells.
Amorim R; Simões ICM; Veloso C; Carvalho A; Simões RF; Pereira FB; Thiel T; Normann A; Morais C; Jurado AS; Wieckowski MR; Teixeira J; Oliveira PJ
Nutrients; 2021 May; 13(5):. PubMed ID: 34069635
[TBL] [Abstract][Full Text] [Related]
10. 4-Octyl Itaconate Prevents Free Fatty Acid-Induced Lipid Metabolism Disorder through Activating Nrf2-AMPK Signaling Pathway in Hepatocytes.
Chu X; Li L; Yan W; Ma H
Oxid Med Cell Longev; 2022; 2022():5180242. PubMed ID: 35222799
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway.
Huang Y; Lang H; Chen K; Zhang Y; Gao Y; Ran L; Yi L; Mi M; Zhang Q
Appl Physiol Nutr Metab; 2020 Mar; 45(3):227-239. PubMed ID: 31173696
[TBL] [Abstract][Full Text] [Related]
12. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
Ganji SH; Kashyap ML; Kamanna VS
Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
[TBL] [Abstract][Full Text] [Related]
14. L-carnitine supplementation attenuates NAFLD progression and cardiac dysfunction in a mouse model fed with methionine and choline-deficient diet.
Mollica G; Senesi P; Codella R; Vacante F; Montesano A; Luzi L; Terruzzi I
Dig Liver Dis; 2020 Mar; 52(3):314-323. PubMed ID: 31607566
[TBL] [Abstract][Full Text] [Related]
15. Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathways.
Chen KY; Lin JA; Yao HY; Hsu AC; Tai YT; Chen JT; Hsieh MC; Shen TL; Hsu RY; Wu HT; Wang GH; Ho BY; Chen YP
Nutr Res; 2018 Apr; 52():87-97. PubMed ID: 29525610
[TBL] [Abstract][Full Text] [Related]
16. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
17. Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function.
Upadhyay KK; Jadeja RN; Vyas HS; Pandya B; Joshi A; Vohra A; Thounaojam MC; Martin PM; Bartoli M; Devkar RV
Redox Biol; 2020 Jan; 28():101314. PubMed ID: 31514051
[TBL] [Abstract][Full Text] [Related]
18. Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
Lu C; Zhang F; Xu W; Wu X; Lian N; Jin H; Chen Q; Chen L; Shao J; Wu L; Lu Y; Zheng S
IUBMB Life; 2015 Aug; 67(8):645-58. PubMed ID: 26305715
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD
Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171
[TBL] [Abstract][Full Text] [Related]
20. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
